Abstract
Drug eluting stent is a new technology aimed to prevent the development of neointimal hyperplasia and restenosis following percutaneous coronary intervention. This review describes the direction for their use at the present time and the future of their utilization with the summary of the principals clinicals trials.
MeSH terms
-
Angioplasty, Balloon, Coronary / instrumentation*
-
Angioplasty, Balloon, Coronary / methods
-
Clinical Trials as Topic
-
Coated Materials, Biocompatible
-
Coronary Disease / therapy*
-
Coronary Restenosis / prevention & control
-
Drug Delivery Systems
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Paclitaxel / therapeutic use
-
Sirolimus / therapeutic use
-
Stents* / trends
-
Tubulin Modulators / therapeutic use
Substances
-
Coated Materials, Biocompatible
-
Immunosuppressive Agents
-
Tubulin Modulators
-
Paclitaxel
-
Sirolimus